Shiqi Zhang

No. 246 Xuefu Road
Harbin, 150086, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Diagnostic challenges in high myopia: identification of sight-threatening complications and the role of artificial intelligence.

Diagnostic challenges in high myopia: identification of sight-threatening complications and the role of artificial intelligence.

Journal: Frontiers in ophthalmology

Published: October 17, 2025

Chitosan-rapamycin carbon dots rejuvenate autologous Sca-1⁺ stem cells paracrine function for neuroprotection in normal tension glaucoma.

Chitosan-rapamycin carbon dots rejuvenate autologous Sca-1⁺ stem cells paracrine function for neuroprotection in normal tension glaucoma.

Journal: Stem cell research & therapy

Published: October 12, 2025

Revealing the role of regulatory microglial IRF7-NLRP3 interactions in optic nerve damage of normal-tension glaucoma based on single-cell RNA sequencing.

Revealing the role of regulatory microglial IRF7-NLRP3 interactions in optic nerve damage of normal-tension glaucoma based on single-cell RNA sequencing.

Journal: Frontiers in immunology

Published: September 08, 2025

Synergistic neuroprotective effects of the ROCK inhibitor Y27632 and atorvastatin in optineurin-E50K-mutant mice through inhibition of scleral fibroblast transdifferentiation.

Synergistic neuroprotective effects of the ROCK inhibitor Y27632 and atorvastatin in optineurin-E50K-mutant mice through inhibition of scleral fibroblast transdifferentiation.

Journal: Experimental eye research

Published: June 16, 2025

Dynamic regulation of thermal-responsive fibers for mitomycin C-controlled delivery on glaucoma drainage device implantation.

Dynamic regulation of thermal-responsive fibers for mitomycin C-controlled delivery on glaucoma drainage device implantation.

Journal: Biomaterials advances

Published: October 05, 2024

Inhibiting NLRP3 Inflammasome Activation to Alleviate Retinal Inflammation and Protect the Optic Nerve of OPTN(E50K)Mice.

Inhibiting NLRP3 Inflammasome Activation to Alleviate Retinal Inflammation and Protect the Optic Nerve of OPTN(E50K)Mice.

Journal: Inflammation

Published: September 30, 2024

Chitosan-Rapamycin Carbon Dots Alleviate Glaucomatous Retinal Injury by Inducing Autophagy to Promote M2 Microglial Polarization.

Chitosan-Rapamycin Carbon Dots Alleviate Glaucomatous Retinal Injury by Inducing Autophagy to Promote M2 Microglial Polarization.

Journal: International journal of nanomedicine

Published: September 13, 2023

Age-related visual impairments and retinal ganglion cells axonal degeneration in a mouse model harboring OPTN (E50K) mutation.

Age-related visual impairments and retinal ganglion cells axonal degeneration in a mouse model harboring OPTN (E50K) mutation.

Journal: Cell death & disease

Published: March 07, 2021

Proteomic analysis of aged and OPTN E50K retina in the development of normal tension glaucoma.

Proteomic analysis of aged and OPTN E50K retina in the development of normal tension glaucoma.

Journal: Human molecular genetics

Published: February 11, 2021

Neuroprotective effects of bone marrow Sca-1+ cells against age-related retinal degeneration in OPTN E50K mice.

Neuroprotective effects of bone marrow Sca-1+ cells against age-related retinal degeneration in OPTN E50K mice.

Journal: Cell death & disease

Published: January 06, 2021

The E50K optineurin mutation impacts autophagy-mediated degradation of TDP-43 and leads to RGC apoptosis in vivo and in vitro.

The E50K optineurin mutation impacts autophagy-mediated degradation of TDP-43 and leads to RGC apoptosis in vivo and in vitro.

Journal: Cell death discovery

Published: November 11, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026